Table 6.
Drug | Method of preparation | Major ingredient | Assembly, device and capsules, flow rate (L/min) | Percentage of FPF | Reference |
---|---|---|---|---|---|
Glucagon | JM | Pharmatose and erythritol | ACI, Jethaler, #2 HPMC, and 28.3 for 10 sec | 33.9 | [72] |
Glucagon | JM | Citric acid and Respitose® SV003 | ACI, Jethaler, #2 HPMC, and 28.3 | 25.0 | [73] |
Insulin | SD | Mannitol, bovine serum albumin, and aspartic acid | ACI, Turbospin, #2 HPMC, and 60 | 83.6 ± 4.7 | [74] |
Insulin | HPH followed by SD | Phospholipon® 90 H and hydrogenated soy lecithin | MSLI, Aerolizer, #3 HPMC, and 100 for 2.4 sec | 63.0 ± 4.0 | [75] |
Influenza subunit vaccine |
SD and SFD | Inulin | MSLI, Twincer®, and 53.7 for 3 sec | 37.00 and 23.00 | [76] |
Pneumococcal surface protein | SD | S. pneumoniae | NGI, Cyclohaler, #3 HPMC, and 60 for 4 sec | 74.31 ± 1.32 | [77] |
Unfractionated heparin | co-SD | L-Leucine (1% w/w) | TSI, Aerolizer, #3 gelatin, and 60 for 5 sec | 13.23 ± 1.65 | [78] |
Recombinant human growth hormone | SD | Polysorbate 20, zinc chloride, and lactose | ACI, Spinhaler, #2 gelatin, and 60 for 4 sec | 38.52 | [79] |
Recombinant antigen 85-B | SD | PLGA | ACI and 60 for 4 sec | 68.9 ± 8.40 | [80] |
SD: spray drying; co-SD: closed spray drying; FD: freeze drying; SFD: spray freeze drying; LP: lyophilization; TFE: thin film evaporation; RE: rotary evaporation; SE: solvent evaporation; TFH: thin film hydration; HPH: high pressure homogenizer; CS: cholesterol; SPC: soybean phosphatidylcholine; HPC: hydrogenated phosphatidylcholine; HSPC: hydrogenated soy phosphatidylcholine; DPPC: dipalmitoyl phosphatidylcholine; DPPG: dipalmitoylphosphatidylglycerol.